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Increasing numbers of illicit and unlicensed medicines are in general circulation and regularly seized by the
police and other regulatory authorities. Forensic identiﬁcation of seized tablets tends to focus on visual
appearance and chromatographic identiﬁcation of the contained drug. This process is relatively time
consuming and places a strain on forensic laboratories. It was therefore of interest to investigate the
possible application of diﬀerential scanning calorimetry (DSC) as a fast and eﬃcient tool to facilitate the
identiﬁcation of contained drug/s and associated tablet excipients. Sixteen diﬀerent cases (Cases A to P)
of diazepam tablets obtained from Police Scotland were characterised based on visual appearance (colour
and manufacturers' logos), physical attributes (size, weight and hardness), drug type, drug quantity (HPLC)
and thermal properties (DSC). Raw DSC data was further processed using principal component analysis
(PCA) as an objective assessment of the thermograms obtained with a view to statistical grouping of
diﬀerent cases. Cases J/K, M/O and L/P could be paired on visual appearance and Cases B/C/E/G and
J/K/L/P on tablet hardness (17–23 and 80–89 N respectively). HPLC indicated that 75% of the cases
examined contained diazepam but less than half of these contained the recognised amount (10 mg);
Cases B/E/L/P contained phenazepam and J/K contained etizolam. The thermal signatures of individual
tablets provided by DSC produced qualitative information about both drugs and excipients, indicating
lactose in Cases D/F/H/I/J/K/M/N/O and Emcompress™ in B/E/L/P. In particular, DSC coupled with PCA
provided conﬁdent groupings of A/C/G, B/E/L/P and H/I/J/K, and speciﬁc pairings of B/E, L/P and F/N.1 Introduction
It is recognised that although the prevalence of prescribed dose
benzodiazepines is generally declining, that of illicit (non-
prescribed) use has been rising steeply since the 1980s and now
presents a major health problem.1,2 Global estimates of non-
medical use of prescription drugs are generally not available
despite such use remaining a major public health concern but
the misuse or non-medical use of benzodiazepines remains
high and, at times, higher than that of many illicit (non-
licensed) substances.3 Polydrug users, particularly heroin
addicts and those on methadone medication, use benzodiaze-
pines to enhance the eﬀect of the opioids.4,5 Benzodiazepines
are also oen cited among other substances reported in both
fatal and non-fatal overdose cases concerning opioid users. In
Scotland, the misuse of benzodiazepines has been directly
linked, or been a contributor to, drug related deaths, withbert Gordon University, Riverside East,
mail: k.h.matthews@rgu.ac.uk
nology, Abertay University, Bell Street,
173 Pitt Street, Glasgow G2 4JS, UK
Chemistry 2015benzodiazepines noted in 28% of the fatalities reported during
2013 and diazepam specically in 20% of all deaths.6 This is
slightly down on the previous year's statistics of 34% for ‘any
benzodiazepine’ and 27% for diazepam.2
Control of these drugs in the UK is compromised by the
increase in the amount of diazepam, for example, purchased
from online pharmacies outside the European Union, mainly
China and India, where the counterfeit trade appears to be
sophisticated.3 Although medicinal solutions of this anxiolytic
are legitimately available for oral and intravenous injection; as
are tablets containing 2, 5 and 10 mg of the active,7 the 10 mg
tablets are most commonly abused.
Apart from the necessary qualitative and quantitative anal-
yses of drug type and content, other important tablet charac-
teristics such as appearance (colour and identifying marks) and
physical attributes such as size, shape, weight and hardness, can
all contribute to forensic classication. Licitly produced tablets
(tablets licensed in the UK) would be expected to conform to
recognised national pharmacopoeial standards whereas illicitly
produced tablets would not necessarily be subject to the same
rigorous rules. Previous work using advanced chromatographic
and spectroscopic methods, e.g. GC-MS, HPLC and SEM-EDXA,
indicated that apart from a lack of control in drug quality,Anal. Methods
Fig. 1 Schematic diagram of a heat ﬂux diﬀerential scanning calo-
rimeter (DSC). Courtesy of http://Hitachi-Hightec.com.
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View Article Onlinequantity and even drug type, diazepam tablets being sold illicitly
oen bear a variety of genuine manufacturers' logos that serve to
confuse the issue of forensic identication.8 In these preliminary
studies, 39% of the individually seized batches contained the
expected quantity of diazepam while 5% contained a lesser
amount. More worryingly, 32% contained a much higher than
expected level of diazepam with one batch containing 48 mg
of the active ingredient i.e. almost ve-times the recommended
dose. Surprisingly, 24% of the batches tested were found to
contain the much more potent and unlicensed (in the UK)
phenazepam and the similarly unclassied thienotria-
zolodiazepine, etizolam.
In addition to drug analysis, identication and character-
isation of tablet excipients, i.e. pharmacologically inert materials
that are blended with the pure drug to enable tablet production,
was also of interest when classifying tablets. To this end, diﬀer-
ential scanning calorimetry (DSC) was investigated for ‘thermal
proling’ of unknown tablets. DSC is a non-standard technique
in the forensic identication of tablets despite being well-estab-
lished as a key analytical tool in preformulation studies within
the pharmaceutical sector.9–11 The method involves heating a
small amount (<10 mg) of powdered sample, contained in a
closed aluminium pan, in a furnace alongside an empty pan and
recording the temperature diﬀerence between both pans, Fig. 1.
Changes to the heat capacity of the sample are indicative of
phase changes or chemical reactions within the sample and are
characteristic for individual samples. Thermal events encoun-
tered typically include dehydration, recrystallization, melting
and degradation. For example, diazepam tablets containing the
common excipient lactose would be expected to show a signal for
the melting of the drug and the dehydration and melting/
degradation of lactose.12 This well-established thermoanalytical
technique was applied to the analysis of disparate tablet seizures
supplied by Police Scotland and the raw data further processed
using principal component analysis (PCA) to evaluate the
grouping of individual tablets in terms of thermal prole.2 Materials and methods
2.1 Materials
Conscated tablets containing ‘diazepam’ were kindly donated
by Police Scotland (Cases A to P). Licit diazepam tablets (28 
10 mg) were supplied by Actavis (Barnstaple, UK) and TevaAnal. Methods(Runcorn, UK) and are coded as ‘Com 1’ and ‘Com 2’ respec-
tively. Diazepam, temazepam, oxazepam, nitrazepam, clonaze-
pam and phenazepam were supplied by Sigma-Aldrich
(Gillingham, UK). Tablet excipients including Maize Starch B.P.
(Thornton & Ross, Hudderseld, UK), calcium phosphate
dihydrate, Emcompress™ (Forum Products, Surrey, UK) and
several grades of lactose monohydrate including ‘Lactose B.P.’
(supplier unknown) – Grade 1; Granulac™ 230 (Meggle, Was-
serburg, Germany) – Grade 2; Pharmatose™ 80 – Grade 5; Lac-
topress™SD, 150, 175 and 300 mm (DFE Pharma, Goch,
Germany) – Grades 4, 3, 6 and 7 respectively – were all analysed
by DSC. Tablet lubricants magnesium stearate and stearic acid,
and tablet binder, poloxomer 407, were also supplied by Sigma-
Aldrich. Polyvinylpyrollidone, PVP (PVP-K25), another common
tablet binder known to be present in commercial products, was
also analysed.
2.2 Measurement of physical attributes
2.2.1 Tablet weight and size. All tablets (16 individual cases
assigned letters A to P) were weighed on a calibrated analytical
balance (Mettler Toledo) and the mean tablet weight and stan-
dard deviation calculated. Tablet thickness was determined at
the point of maximum depth and tablet diameter was measured
in the direction of the score line using a digital calliper (150 cm,
110 DBL series, Stanton, London, UK). The absolute number of
tablets available varied from case to case.
2.2.2 Tablet hardness (‘crushing strength’). The force
required to cause mechanical failure of individual tablets was
performed using a THB 28 tablet hardness tester (Erweka,
Heusenstamm, Germany). Following careful cleaning of the test
platform, individual tablets were placed at on the platform
with the diameter parallel and the score line (if present)
perpendicular to the plane of the compressive force. The
applied force at which the tablet undergoes catastrophic
mechanical failure was recorded and the crushed tablets and
associated fragments/powder carefully removed to a clean, dry
glass sample bottle. Crushed samples were labelled according
to the case code and individually numbered for easy identi-
cation prior to analysis by DSC.
2.3 Visual analysis and drug content
2.3.1 Visual analysis. Colour photographs of individual
tablets were taken using a Nikon D3200 DSLR camera tted with
a Sigma EX 105 mm macro lens and a 58 mm skylight lter
(Jessops, Marlow, England).
2.3.2 Drug content by HPLC. High performance liquid
chromatography, HPLC, was used to identify and quantify the
drug content of each batch of tablets. A prominence UFLC
system with DAD detection in the region 200–400 nm (Shi-
madzu, Kyoto, Japan) coupled with a C18 Gemini analytical
column, 250  4.6 mm i.d. and 5 mm sized stationary phase
(Phenomenex, Maccleseld, UK) was used. Prior to tablet
analysis, calibration was undertaken with the pure benzodiaz-
epine samples. Individual samples (1 mg) were dissolved in
acetonitrile (1 mL) and 0.1 M HCl added to a nal volume of
5 mL giving a concentration of 0.2 mg mL1. All solutions wereThis journal is © The Royal Society of Chemistry 2015
Table 1 Identiﬁcation of individual tablets containing details of visible
markings (logos), a summary of the key excipients identiﬁed by DSC
and the diazepam content as determined by HPLC
Case code Markings Excipients detected
Diazepam content
(mg per tablet)
Com 1 “C/DC” Lactose, stearic acid 8.79
Com 2 “10” Lactose 8.48
A No markings Stearic acid, no lactose 7.32
B “MA/D10” Emcompress, no lactose 0 (Phenazepam)
C “MA/D10” Stearic acid, no lactose 7.15
D “COX/DC” Lactose (amorphous) 23.24
E “MA/D10” Emcompress, no lactose 0 (Phenazepam)
F “MSJ”
(small tablet)
Lactose 7.58
G “MA/D10” Stearic acid, no lactose 6.61
H “COX/DC” Lactose (amorphous) 23.38
I “COX/DC” Lactose (amorphous) 23.11
J “MA/D10” Lactose (amorphous) 0 (Etizolam)
K “MA/D10” Lactose (amorphous) 0 (Etizolam)
L “10” Emcompress, no lactose 0 (Phenazepam)
M “MA/D10” Lactose (amorphous) 9.52
N “Tensium” Lactose 9.37
O “MA/D10” Lactose (amorphous) 9.73
P “10” Emcompress, no lactose 0 (Phenazepam)
Fig. 2 Photographic images of licit (Com 1 and Com 2) and illicit
‘diazepam’ tablets. Individual Cases A to P are included.
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View Article Onlinestored in a refrigerator at 3 C to minimise hydrolysis. An
injection volume of 20 mL was used. The mobile phase was
composed of a phosphate buﬀered solution (4.8 g of dihydrogen
potassium orthophosphate and 1.2 mg of dipotassium
hydrogen orthophosphate anhydrous dissolved in 1000 mL
distilled water, adjusted to pH 6.0  0.5 with 0.1 M HCl, Eluent
A) and HPLC grade acetonitrile, Eluent B (Fisher Scientic,
Loughborough, UK).
A randomly selected tablet from each batch was crushed in a
mortar and pestle and approximately 20 mg was accurately
weighed and transferred to a volumetric ask (10 mL) and
acetonitrile (2 mL) added followed by 0.1 M HCl to 10 mL giving
a nal concentration of 2.0 mg mL1. Samples for analysis were
ltered (1 mL Plastipak syringe and disposable 0.45 mm What-
man syringe iter) prior to injection (20 mL). A mobile phase
gradient of 75 : 25 (Eluent A : Eluent B) was changed to 45 : 55
over 31 minutes, held for 4 minutes and returned to 75 : 25 at
35 minutes. Peak integration was undertaken using LC solu-
tions soware. Values quoted in Table 1 are the mean of 3
measurements from each case.
2.4 Thermoanalytical analysis by diﬀerential scanning
calorimetry
2.4.1 Calibration of instrument. Prior to a particular
sequence of sample measurements, the DSC was calibrated
using an indium standard (Tm ¼ 156.6 C) at the heating rate
used (10 Cmin1). All eﬀorts to reduce external contamination
of the heating cell and sample pans were undertaken.
2.4.2 Analysis of a selection of benzodiazepines. Pure
samples (5–10 mg) of diazepam, temazepam, oxazepam, nitra-
zepam and clonazepam were accurately weighed (0.05 mg)
placed in non-hermetically sealed, standard aluminium pansThis journal is © The Royal Society of Chemistry 2015(40 mL) and heated from 20–250 C under a constant ow rate of
nitrogen (50 mL min1) in a Q100 series DSC (TA Instruments,
Newcastle, USA) at a heating rate of 10 C min1.
2.4.3 Analysis of a selection of sugars. Pure samples (5–10
mg) of a selection of sugars that may be used as tablet excipi-
ents, namely, glucose, fructose, trehalose, sorbitol, mannitol
and lactose were placed in standard aluminium pans and
heated from 20–250 C at 10 C min1.
2.4.4 Analysis of a selection of tablet excipients. Samples
(5–10 mg) of Maize Starch B.P., Emcompress™, poloxamer 407,
PVP, stearic acid and magnesium stearate, a common tablet
lubricant, were placed in individual, standard aluminium pans
and heated from 20–250 C at 10 C min1.
2.4.5 Analysis of a selection of lactose grades. A sample
(5–10 mg) of diﬀerent commercial grades of lactose typically
used for tablet manufacture were placed in individual, standard
aluminium pans and heated from 20–250 C at 10 C min1.
2.4.6 Analysis of licit and illicit tablets. Tablet samples
were crushed and nely ground in a small agate mortar and
pestle. Samples of each tablet (5–10 mg) were placed in a stan-
dard aluminium pan and heated from 20–250 C at 10 Cmin1.
In addition to normal processing of DSC data using TA
universal analysis soware (version 4.3), principal component
analysis (PCA) was performed on the raw heat ow data from
25–213 C using Unscrambler® X (Camo Soware AS, Oslo,
Norway). The rationale for this was to further objectify the DSC
data with a view to producing statistical matches of disparate
tablets.3 Results and discussion
3.1 Physical attributes
With the exception of Case F, much smaller in diameter (5.55 
0.01 mm) than all the other cases which ranged from 8.03
(A and N)–8.15 mm (G), only Cases C/G and A/N could be
condently distinguished from the rest based on mean diam-
eter and standard deviation. Most notable from considerationAnal. Methods
Fig. 3 DSC thermograms of ﬁve diﬀerent benzodiazepines at a
heating rate of 10 C min1 indicating the individual melting points.
Values of Tonset and Tmax and the enthalpy of fusion (J g
1) are indi-
cated for each pure compound.
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View Article Onlineof mean tablet weights was the relatively small standard devi-
ations obtained for the two licit cases, Com 1 and Com 2
(0.0014–0.0017 g). These values should be compared with Cases
E and I (0.0133–0.0138 g) respectively which showed the highest
deviations in weight. All other cases had relatively narrow
deviations from the individual mean tablet weights
(0.0016–0.0084 g). For the purposes of comparison of all
batches, mean weight was of limited value. Of much more value
was comparison of tablet hardness. Clear and signicant
diﬀerences were apparent between Cases B/C/E/G, which were
soer (17–23 N) than all the others, the hardest tablets being J/
K/L/P (80–89 N).
Measurement of tablet thickness indicated highly variable
results ranging from 2.4367 0.0635 mm (F) to 3.5200 0.0872
mm (A). The narrowest standard deviations from the mean
(<0.03 mm) were obtained for Cases C/L/M/O/P, Com 1 and Com
2. Based on these physical attributes alone, Cases B/C/E/G and
J/K/L/P were grouped with low condence.
3.2 Visual analysis
Tablet markings indicated that Cases B/C/E/G (“MA/D10”), J/K
(“MA/D10”) and L/P (“10”) may be grouped based on logo alone
but there remained discrepancies between the absolute font
type and character spacing (see Cases E and G – spacing of the
numbers “1” and “0” and Cases K and L – diﬀerent logos),
Table 1 and Fig. 2. Based on visual observation of colour alone,
only Cases J/K, L/P and M/O showed any resemblance, however,
too much variability between colour, hue and distribution of
dye substance rendered subjective assessment of little use.
3.3 Drug type and content
Denitive identication of the specic drug and its content in
individual tablets was of primary importance for forensic
identication. HPLC identied two distinctly diﬀerent benzo-
diazepines (diazepam and phenazepam) and the thieno-
triazolodiazepine, etizolam in particular cases (Table 1). This
enabled Cases B/E/L/P to be related based on phenazepam
content although the precise quantity per tablet was not deter-
mined at this stage in these studies. Identication of etizolam
in Cases J and K (quantities unknown) suggested a connection
supported by testing of physical attributes, markings and colour
(Fig. 2). All other tablets tested contained varying levels of
diazepam from 6.61 mg per tablet for Case G to 23.38 mg per
tablet for Case H (Table 1). Based on the recognised doses of 2, 5
and 10 mg per tablet, diazepam content of the licit batches
(Com 1 and Com 2) were actually less than the expected 10 mg
per tablet. The British Pharmacopoeia12 species that for
uniformity of (drug) content, not more than one tablet should
deviate from 85–115% of the average content of 10 tablets.
Clearly, Com 2 is on the lower limit of this specication but
would have passed the manufacturer's quality system. This is
also true of Cases M, N and O which contain 9.52, 9.37 and
9.73 mg per tablet diazepam respectively. In contrast, Cases A,
C, D, F, G, H and I would fail the pharmacopoeial test by a
considerable amount. Most worryingly are the dangerously high
levels of diazepam in Cases D, H and I of 23.24, 23.38 andAnal. Methods23.11 mg per tablet respectively. It may be safe to assume that
based on diazepam content alone, only Cases M, N and O could
be construed as licitly produced.3.4 Diﬀerential scanning calorimetry
3.4.1 Benzodiazepines. An overlay of the thermograms for
the ve diﬀerent benzodiazepines analysed by DSC (Fig. 3)
indicated ve distinct and sharply dened endothermic events
attributed to the individual melting point of each pure
compound. The onset temperatures, in increasing order, were
130.3 C (diazepam), 158.5 C (temazepam), 194.3 C (oxaz-
epam), 227.0 C (nitrazepam) and 238.4 C (clonazepam). These
can be compared with the literature values of 125–126 C
(diazepam), 119–121 C (temazepam), 205–206 C (oxazepam),
224–226 C (nitrazepam) and 236.5–238.5 C (clonazepam).13
Clearly, there are signicant discrepancies in the values of
melting point determined in these studies by DSC for temaze-
pam, diazepam and oxazepam compared to the quoted litera-
ture values. It should be noted that the quoted values take no
account of polymorph or pseudopolymorph (solvate) formation
and refer to crystals from specic solvents with melting points
determined using traditional laboratory melting point appa-
ratus. The three benzodiazepines showing discrepancies in this
study, like most drug substances, are known to exhibit poly-
morphism.14 Using DSC, melting for diazepam has been
recorded at 132.8 C,15 132 C16 and 132.3 C (unspecied
forms);17 118 C (Form V), 120 C (Form III), 136 C (Form
I-solvate), 134 C (Form VI-hydrate) and 157 C (Form VII-
solvate).18 A metastable form of temazepam has been recorded
at 159 C14 that can be compared with the widely quoted value of
119–121 C for ‘crystals from cyclohexane’.13 The melting of
oxazepam (Form IV)19 is recorded at 195 C but known to
coincide with decomposition rendering the value for the
enthalpy of the melt transition quoted in Fig. 3 indeterminate.
Although unable to give unambiguous indication of the specic
polymorphic form of a substance as a stand alone technique in
the absence of denitive X-ray crystallographic data, for theThis journal is © The Royal Society of Chemistry 2015
Fig. 4 DSC thermograms of six sugars commonly used as tablet
excipients.
Fig. 5 Grade 1-Lactose B.P. (supplier unknown); Grade 2-Gran-
ulac™230; Grade 3-Lactopress™150; Grade 4-Lactopress™SD; Grade
5-Pharmatose™80; Grade 6-Lactopress™175; Grade 7-
Lactopress™300.
Fig. 6 DSC thermograms of ﬁve common tablet excipients for illus-
trative purposes.
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View Article Onlinepurposes of this study, DSC is able to quickly distinguish
between the diﬀerent types of benzodiazepine that may be
present in an unknown tablet sample. In these studies, 66% of
the tablets tested showed evidence of a sharp melt transition
around 130 C indicative of diazepam, supported by the results
of HPLC analysis summarised in the previous section.
3.4.2 Common tablet excipients. Sugars are commonly
used as tablet llers or diluents, lactose being by far the most
common.20 Other sugars or sugar alcohols such as glucose,
sucrose or sorbitol, and more rarely trehalose or fructose,21 can
also be used. Samples of each of these sugars were analysed by
DSC using a single heating run and presented in Fig. 4.
Distinctive thermal signatures were apparent for all samples
indicating mainly, dehydration, melting and degradation
events. Lactose being the most common tablet excipient was of
particular interest and showed a clear dehydration of the
a-monohydrate to the a-anhydrous form with an onset
temperature of 142.6 C.12,20,21 Melting of the a-anhydrous form
was immediately followed by decomposition, indicated by an
erratic baseline. No evidence of the recrystallization of amor-
phous lactose was evident around 167 C.12
Several diﬀerent pharmaceutical grades of lactose
(numbered 1–7-see Section 2.1) were analysed by DSC (Fig. 5)
and some minor variation in the peak temperature of 144–150
C for dehydration of a-lactose monohydrate and observable
diﬀerences in the peak width were apparent. Grades 4, 6 and
7 showed some evidence of amorphous content (167 C) that
was much less notable in the other grades tested. As an aside,
Grade 3 indicated the probable melting of b-anhydrous lactose
at 227 C.
Other common tablet excipients tested included the binders
maize starch, PVP and poloxamer 407, and the lubricants
magnesium stearate and stearic acid (known to be present in
Com 1). A variety of thermal behaviours were apparent for these
four excipients and are shown in Fig. 6.
Briey, magnesium stearate indicated a broad melting range
of 110–125 C typical of commercial samples;21 stearic acid
displayed a well-dened endotherm with an onset of 68.6 C
and a weaker endotherm with onset 55.71 C, the latter eventThis journal is © The Royal Society of Chemistry 2015being attributed to <10% (w/w) palmitic acid content which
appears to be common;12 poloxomer 407 (a synthetic co-poly-
ether) displayed a sharp melt at 53.3 C and maize starch
produced a very broad displacement of the base line between 20
and 160 C known to be associated with the desorption of water
as a function of increasing temperature during measurement.
PVP displayed a largely non-descript thermogram showing a
small dri in the baseline (heat capacity) most probably asso-
ciated with desorption of water as for maize starch. No other
thermal events were detected to 200 C.
3.4.3 Licit and illicit ‘diazepam’ tablets.With the benet of
the DSC data presented in Fig. 3–6, analysis of all the available
tablets, including the two licit commercial types (Com 1 and
Com 2) quickly indicated that eleven of the eighteen test cases,
including the licit tablets, contained lactose as ller/diluent. Of
these eleven tablets, all but three showed clear signs of amor-
phous lactose as evidenced by a signicant exothermic event
around 167 C attributed to recrystallization of amorphous
lactose to the a-anhydrous crystalline state (Fig. 7). Both licit
tablets and Case N did not show evidence of amorphous lactose.Anal. Methods
Fig. 7 DSC thermograms of seven selected cases all containing
lactose as the bulk excipient and including Com 1 and Com 2 for
comparison. Note the apparent absence of amorphous lactose
content in both licit samples and Case N.
Fig. 9 DSC thermograms of Cases B, E, L and P containing
Emcompress™ as the bulk excipient.
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View Article OnlineThe presence of diazepam was clearly resolved in Com 2 and to
a lesser extent in Com 1. It should be noted that any interaction
between drug and excipient/s and/or changes to the degree of
drug crystallinity as a result of processing conditions can aﬀect
the resolution of the drug melting endotherm. The fact that
diazepam is less clearly resolved in Com 1may be attributable to
any of these factors. Both licit tablets, Com 1 and Com 2, con-
tained 8.79 and 8.48 mg of diazepam per tablet respectively, as
measured by HPLC (Table 1). Com 1 gave a weak but relatively
sharp signal corresponding to the melting of stearic acid, a
tablet lubricant, as might have been expected from consider-
ation of the manufacturer's labelling. Of the remaining ten
cases containing diazepam, the high levels of drug measured
for Cases H, I (Fig. 7) and D (see Fig. 10) indicated a more
intense signal for diazepam compared with all the other diaz-
epam-containing tablets. This indication was corroborated by
the diazepam contents as determined by HPLC of 23.24, 23.38
and 23.11 mg per tablet respectively (Table 1).
Cases A, C and G showed no sign of lactose content, giving a
fairly broad and (as yet) uncharacterised endothermic eventFig. 8 DSC thermograms of Cases A, C and G containing diazepam
and an (as yet) unidentiﬁed excipient.
Anal. Methodsfrom 115–150 C that included a clear signature peak for diaz-
epam (Fig. 8). Cases B, E, L and P similarly showed no evidence
for lactose but were clearly composed of the alternative tablet
ller/diluent known as ‘Emcompress’, a trade name for calcium
hydrogen phosphate dihydrate.21 HPLC indicated that these
particular tablets contained the unlicensed phenazepam
(results not shown) a potent benzodiazepine that has only
recently been classied in the UK and is known to be around
ve-times more potent than diazepam.22,23 Two polymorphic
forms of phenazepam have recently been reported with melting
points of 207–212 C (b-form) and 226–227 C.24 No evidence of
either of these transitions was apparent in the DSC results
presented (Fig. 9). Possible reasons could be attributed to the
proximity of the main Emcompress dehydration event causing
major perturbations within the sample pan and a resultant loss
of a distinct signal for the drug, or the drug content being too
low for detection. A combination of these factors may also be
involved.
It was concluded that DSC is a fast and eﬀective method of
tablet analysis able to reveal both crude and subtle diﬀerences
between disparate batches of tablets. This capability isFig. 10 DSC thermograms of a selection of cases grouped by bulk
excipient. Note the signiﬁcant diﬀerences between Cases D and F
which both contain lactose.
This journal is © The Royal Society of Chemistry 2015
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View Article Onlineillustrated in Fig. 10 where seven separate cases can be quickly
grouped into three distinct sets based on the bulk excipients i.e.
A/C/G (unknown excipient), B/E (Emcompress) and D/F
(lactose). Comparison of Cases D and F indicates signicant
diﬀerences in the lactose ‘signature’ that suggest tablets of
diﬀerent origin and this is supported by the appearance of
distinctly diﬀerent tablet logos and markings (Fig. 2).
3.4.4 Principal component analysis (PCA) of DSC data. PCA
is a widely used chemometric technique that reduces the
dimensionality of multivariate data. In essence, a matrix of the
covariances of each of the variables (heat ow and temperature)
is produced and the eigenvectors are determined. The scalar
magnitude of each eigenvector is reduced to unit length and
labelled as a principal component (PC) which represents a
“latent axis” of variability within the dataset. The PCs are
ranked according to their eigenvalues, the largest of which
holds the greatest variability. This is an unsupervised technique
and existence of a correlation between samples is highlighted
by clustering in a scores plot. It was undertaken on all DSC data
to remove subjectivity of observation. PCA of DSC data on all
tablets included in this study is represented by the scores plot,
Fig. 11. Cases B/E and L/P are far-removed from all other cases,
the stated pairings being consistent with tablet hardness,
weight, visual analysis and HPLC (phenazepam). Another clear
grouping based on DSC alone is Cases H/I/J/K, the pairing of J
and K corroborated by hardness, visual analysis and GC-MS
(etizolam). Cases H and I were closely related based on visual
analysis and drug content by HPLC (diazepam). Of the
remainder of the cases investigated, including the two known
commercial samples, Cases A, C and G did not contain lactose
or Emcompress (bulk excipient as yet unknown) but contained
similar quantities of diazepam. In addition to this clear
grouping, C/G and A/N could be paired on mean tablet diameter
and deviation, however, only Cases C and G shared the mark-
ings “MA/D10” with A and N showing no markings and “Ten-
sium” respectively.
Finally, the bulk of the cases containing lactose as the main
excipient were closely grouped by PCA as might be expected and
discrepancies relating to the relative magnitude of diazepamFig. 11 Scores plot for all cases examined (A to P) indicating unam-
biguous groupings of diﬀerent cases. Note that B, E, L and P can be
further grouped into pairs and that A/C/G and H/I/J/K from distinct
groups.
This journal is © The Royal Society of Chemistry 2015content (height of the diazepam melt transition relative to the
dehydration of lactose) and the conspicuous signature associ-
ated with the presence of amorphous lactose, were dis-
tinguishing features readily revealed by DSC that aided further
correlation of diﬀerent cases.4 Conclusions
DSC is a fast and eﬀective method for generating the thermal
prole of unclassied tablets that can be used in conjunction
with other characterisation methods to denitively highlight
any similarities between individual batches of tablets. This
ability makes it invaluable as a method for the forensic identi-
cation of tablets.Acknowledgements
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